From: Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance
Characteristics | patients (nā=ā106) | Ku80 mRNA level | Ā | P | Ku80 protein level | Ā | P |
---|---|---|---|---|---|---|---|
Low (nā=ā28) | High (nā=ā78) | Low (ānā=ā23) | High (nāā=ā83) | ||||
Age at diagnosis of lung AC | Ā | Ā | Ā | 0.202 | Ā | Ā | Ā |
mean Ā± SD | 58.33āĀ±ā10.50 | 57.45āĀ±ā9.96 | 60.79āĀ±ā11.71 | Ā | Ā | Ā | Ā |
Gender | Ā | Ā | Ā | 0.371 | Ā | Ā | 0.151 |
Male | 43(40.6) | 9(32.1) | 34(43.6) | Ā | 6(26.1) | 37(40.6) | Ā |
Female | 63(59.4) | 19(67.9) | 44(56.4) | Ā | 17(73.9) | 46(55.4) | Ā |
Smoking status | Ā | Ā | Ā | 0.238 | Ā | Ā | 0.13 |
Never | 32(30.2) | 11(39.3) | 21(26.9) | Ā | 10(43.5) | 22(26.5) | Ā |
Former and current smokers | 74(69.8) | 17(60.7) | 57(73.1) | Ā | 13(56.5) | 61(73.5) | Ā |
Tumor grade | Ā | Ā | Ā | 0.062 | Ā | Ā | 0.114 |
Well differentiated | 36(34.0) | 15(53.6) | 21(34.0) | Ā | 12(52.2) | 24(28.9) | Ā |
Moderately differentiated | 32(30.2) | 7(25.0) | 32(30.2) | Ā | 5(21.7) | 27(32.5) | Ā |
Poorly differentiated | 38(35.8) | 6(21.4) | 32(35.8) | Ā | 6(26.1) | 32(38.6) | Ā |
Lymph node metastasis | Ā | Ā | 0.001 | Ā | Ā | 0.001 | |
Positive | 73(68.9) | 11(39.3) | 62(79.5) | Ā | 6(26.1) | 67(80.7) | Ā |
Negative | 33(31.1) | 17(60.7) | 16(20.5) | Ā | 17(73.9) | 16(19.3) | Ā |
Disease stage | Ā | Ā | Ā | 0.014 | Ā | Ā | 0.017 |
I | 23(21.7) | 10(35.7) | 13(16.7) | Ā | 10(43.5) | 13(21.7) | Ā |
II | 57(53.8) | 13(46.4) | 44(56.4) | Ā | 9(39.1) | 48(53.8) | Ā |
III | 26(24.5) | 5(17.9) | 21(26.9) | Ā | 4(17.4) | 22(26.5) | Ā |